Cryotherapy for OSA

About Cryosa

Cryosa is a privately held, clinical-stage biotech company pioneering a non-invasive treatment for obstructive sleep apnea (OSA) using a proprietary cryotherapy platform. Founded in 2015 and based in Maple Grove, Minnesota, the company is advancing its lead program through a U.S. pilot study (ARCTIC-3), having secured significant venture funding to date. Cryosa aims to address the large unmet need in the OSA market, where current standard-of-care options like CPAP machines suffer from poor patient tolerance and adherence.

Therapeutic Areas